hyaluronoglucosaminidase has been researched along with Congenital Immunodeficiency Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engler, F; Follman, K; Freshwater, E; Li, Z; Yel, L | 1 |
| Angelotti, F; Capecchi, R; Giannini, D; Mazzarella, O; Migliorini, P; Rocchi, V | 1 |
2 other study(ies) available for hyaluronoglucosaminidase and Congenital Immunodeficiency Disease
| Article | Year |
|---|---|
Effects of Body Mass and Age on the Pharmacokinetics of Subcutaneous or Hyaluronidase-facilitated Subcutaneous Immunoglobulin G in Primary Immunodeficiency Diseases.
Topics: Adult; Child; Health Status; Humans; Hyaluronoglucosaminidase; Immunoglobulin G; Immunoglobulins, Intravenous; Primary Immunodeficiency Diseases | 2023 |
Long-term efficacy, safety, and tolerability of recombinant human hyaluronidase-facilitated subcutaneous infusion of immunoglobulin (Ig) (fSCIG; HyQvia(
Topics: Adolescent; Adult; Aged; Antigens, Neoplasm; Drug Administration Schedule; Female; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Immunoglobulins, Intravenous; Immunologic Factors; Infusions, Subcutaneous; Male; Middle Aged; Primary Immunodeficiency Diseases; Recombinant Proteins; Retrospective Studies; Treatment Outcome; Young Adult | 2020 |